Nifekalant Versus Amiodarone in the Treatment of Cardiac Arrest: an Experimental Study in a Swine Model of Prolonged Ventricular Fibrillation

被引：0
作者：
George Karlis
Nicoletta Iacovidou
Pavlos Lelovas
Panagiota Niforopoulou
Apostolos Papalois
Ioanna Siafaka
Spyros Mentzelopoulos
Theodoros Xanthos
机构：
[1] Sismanoglio General Hospital,2nd Department of Internal Medicine
[2] Hellenic Society of Cardiopulmonary Resuscitation,2nd Department of Obstetrics and Gynecology, Neonatal Division
[3] Aretaieio Hospital,1st Anesthesiology Clinic, Pain Relief and Palliative Care Unit
[4] National and Kapodistrian University of Athens,1st Department of Intensive Care Medicine
[5] Medical School,MSc “Cardiopulmonary Resuscitation”
[6] Experimental-Research Center ELPEN Pharmaceutical,undefined
[7] Aretaieio Hospital,undefined
[8] National and Kapodistrian University of Athens,undefined
[9] Medical School,undefined
[10] National and Kapodistrian University of Athens,undefined
[11] Medical School,undefined
[12] National and Kapodistrian University of Athens,undefined
[13] Medical School,undefined
[14] Midwestern University of Chicago,undefined
来源：
Cardiovascular Drugs and Therapy | 2015年 / 29卷
关键词：
Arrhythmia; Cardiopulmonary resuscitation; Antiarrhythmic drug; Cardiac arrest; Nifekalant; Amiodarone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：425 / 431
页数：6
相关论文
共 103 条
[1]  
Deakin CD(2010)European resuscitation council guidelines for resuscitation. Section 4. Adult advanced life support Resuscitation 81 1305-1352
[2]  
Nolan JP(2010)Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Circulation 122 729-767
[3]  
Soar J(2010)Part 8: advanced life support. 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations Resuscitation 81 93-174
[4]  
Neumar RW(1999)Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation N Engl J Med 341 871-878
[5]  
Otto CW(2002)Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation N Engl J Med 346 884-890
[6]  
Link MS(1995)Cellular electrophysiological effects of MS-551, a new class III antiarrhythmic agent Drug Dev Res 35 61-68
[7]  
Deakin CD(2010)Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia Resuscitation 81 47-52
[8]  
Morrison LJ(2009)Effects of intravenous nifekalant as a life saving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome Circ J 73 2021-2028
[9]  
Morley PT(2006)Comparison of nifekalant and lidocaine for the treatment of shock-refractory ventricular fibrillation Circ J 70 442-446
[10]  
Kudenchuk PJ(2010)Nifekalant hydrochloride for patients with cardiac arrest caused by shockable rhythm Circ J 74 2308-2313
12345678910